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ABSTRACT
To identify factors associated with Escherichia coli meningitis (ECM) mortality in infants aged <3 months,
the clinical, biological and bacterial characteristics of isolates from 99 cases of ECM were compared,
including the phylogenetic group, multilocus sequence type, O serogroup and sequence O type
(a combination of sequence type complex (STc) and O serogroup) and virulence genotype. All 99 isolates
were susceptible to the initial antimicrobial treatment. The mortality rate (14%) was not influenced by
term or post-natal age. Hypotension or seizures were the sole clinical predictive factors for fatal outcome
(p <0.01), and abnormal initial trans-fontanellar ultrasound was associated with death (p 0.03). Seventy-
seven isolates belonged to the common sequence O types (STc29O1, STc29O18, STc29O45, STc301O7,
STc304O16, STc697O83, STc700O1) causing neonatal meningitis. None of the phylogenetic groups and
none of the virulence determinants were distributed differently between survivors and non-survivors,
except that the aerobactin gene (iucC) was less frequent in lethal isolates (94% vs. 71%, p 0.02). Isolates
belonging to rare sequence O types were more likely to be lethal (OR 4.3, p 0.01), although they induced
a lower level of bacteraemia than common sequence O types such as STc29O18 and STc29O45 in a
neonatal rat model. These results suggest that unidentified human genetic risk-factors may be more
important than strain virulence in predicting ECM mortality.
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INTRODUCTION
Neonatal bacterial meningitis is associated with
high mortality and morbidity rates [1]. In indus-
trialized countries, Escherichia coli is the leading
cause of meningitis in premature neonates [2] and
the second cause, after group B streptococci, in
term neonates [1]. No studies of the clinical and
biological characteristics and prognostic factors of
E. coli meningitis (ECM) in young infants have
been published for more than 15 years. Advances
in neonatal intensive care, the increasing
frequency of premature birth, the advent of
third-generation cephalosporins in the 1980s and
the emerging use of ciprofloxacin [3] may have
changed the prognosis of ECM. In addition, our
understanding of ECM pathogenesis has pro-
gressed during the last decade, following the
identification of specific virulence factors and the
genotyping of E. coli strains causing meningitis
[4–7]. In the present study, patient-related vari-
ables and bacterial characteristics were examined
in infants with ECM in order to identify factors
associated with vital outcome.
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MATERIALS AND METHODS
Cases of ECM occurring between 1988 and 2004 were
collated from the microbiological register of the French
National Reference Laboratory, which receives E. coli isolates
obtained from cerebrospinal fluid samples from throughout
France. All of these cases were spontaneously referred to the
Reference Laboratory with minimal clinical data. Patients
with congenital central nervous abnormalities were
excluded. Meningitis in young infants was defined by
isolation of E. coli from the cerebrospinal fluid of infants
aged <3 months. For the present study, a standardized data
collection form was sent to the referring clinicians to obtain
demographic data, the infants’ clinical status before the
onset of meningitis, the vital signs upon admission and after
treatment for 12 h, trans-fontanellar sonography result upon
admission, initial laboratory findings, antibiotic treatment
and vital outcome.
All of the isolates have been characterized previously [6],
including: (i) the phylogenetic group (A, B1, B2 and D); (ii) the
sequence O type, defined as the combination of the sequence
type complex (STc, obtained from the EcMLST website;
http://www.shigatox.net) and serogroup [6]; and (iii) the
virulence genotype, based on PCR detection of virulence
factors involved in the survival of E. coli in serum, e.g.
antigen K1, iron-uptake systems (fyuA, iroN, iucC), haemolysin
(hlyC), and genetic determinants involved in blood–brain
barrier penetration, such as the adhesin S fimbriae (sfaS), the
endothelial invasin (ibeA), and the cytotoxin necrotising factor
CNF1 (cnf1) [4,6,8]. Common sequence O types were defined
as those representing ‡5% of isolates in the recent worldwide
epidemiological meningitis study of 186 ECM isolates (i.e.
STc29O1, STc29O18, STc29O45, STc301O7, STc304O16, STc697O83,
STc700O1) [6]. Antibiotic susceptibility was tested by the disk-
diffusion technique according to the recommendations of the
Antibiogram Committee of the French Society for Microbio-
logy (http://www.sfm.asso.fr).
For the present study, isolates with uncommon sequence
O types that were associated with fatal outcome were studied
in a neonatal rat model [9]. In brief, 4-day-old pathogen-free
Sprague–Dawley rats (Janvier Laboratories, Le Genest-St-Isle,
France) were inoculated intraperitoneally with 600 CFU sus-
pended in normal saline. After a further 18 h, 5 lL of blood
was obtained by tail incision and bacteria were counted by
culture (detection limit, 100 CFU ⁄mL).
Student’s test or the non-parametric Mann–Whitney test
was used to identify inter-group differences among continu-
ous variables, and the chi-squared test or Fisher’s exact test
was used to compare categorical variables, with p <0.05
considered to denote statistical significance. Multivariable
analysis could not be used to identify factors related to
mortality, because the number of deaths was small [10].
RESULTS
Patient characteristics, biological data and
imaging findings
Responses were received to 102 (76%) of the 134
questionnaires sent out. Three patients were
subsequently excluded (one patient who had
received neurosurgery, and two patients aged
>3 months). In total, 99 cases met the eligibility
criteria. The characteristics of the study popula-
tion are shown in Table 1. At diagnosis, the
median post-natal age was 10 days (range
0–90 days), and 83 infants were neonates
(£28 days). Thirty-three infants were born prema-
turely, ten of whom had a gestational age of
<32 weeks, and 23 who had a gestational age of
32–37 weeks. Symptoms occurred <24 h before
admission in 70% of cases. Thermal instability
was the most frequent clinical finding (74%).
Trans-fontanellar sonography was performed
upon admission in 83 cases and was abnormal
in one-third of cases. Overall, 8% of the patients
had ventriculitis (n = 7), 4% had subdural effu-
sion (n = 3), 6% had ventricular dilation (n = 5),
13% had parenchymal haemorrhage (n = 11), and
1% had cerebral oedema (n = 1).
Treatment
All the isolates were susceptible to the initial
treatment, with 97 infants being treated initially
with a combination of cefotaxime and an amino-
glycoside, while two infants received amoxycillin
and an aminoglycoside. In keeping with local
protocols, 44% of the infants also received intra-
venous ciprofloxacin (20–30 mg ⁄ kg ⁄day) for the
first 5 days of treatment, regardless of their initial
clinical status (Table 1).
Characteristics of the strains
The distribution of phylogenetic groups, com-
mon sequence O types and virulence determi-
nants among the 99 E. coli isolates is
summarized in Table 1. No difference in the
phylogenetic group distribution was observed
between term and preterm infants (data not
shown). Seventy-seven isolates belonged to the
common sequence O types causing neonatal
meningitis. Each common sequence O type was
represented by at least four isolates, with
the exception of STc304O16 (one isolate), which
is frequent in the USA, but rare in France [6].
The uncommon sequence O types STc27O25,
STc27O6, STc171O2, STc171O16, STc171O21,
STc171O14, STc171ONT, STc260O77, STc260ONT,
STc280O35, STc354O35, STc379O128, STc382O5,
STc689O77, STc692O83, STc696O83, STc698O14 and
686 Clinical Microbiology and Infection, Volume 14 Number 7, July 2008
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 685–690
STc699O23 were each represented by one strain,
and STc259O8 and STc279ONT were each repre-
sented by two strains. Uncommon sequence O
type strains had significantly fewer virulence
factors than their more common counterparts
(capsular antigen K1, 77% vs. 97%, p 0.001;
iroN, 36% vs. 86%, p 0.0003; mean number of
virulence factors per strain ± SD: 4.8 ± 1.3 vs.
5.9 ± 1.2, p <0.0001). Preterm infants were more
likely than term infants to be infected by strains
belonging to uncommon sequence O types (39%
vs. 15%, p 0.007), and none of the virulence
factors was distributed unevenly between term
and preterm infants (data not shown).
Factors associated with vital outcome in
univariate analysis (Table 1)
The overall case fatality rate was 14%, with rates
of 18% (6 ⁄ 33) in preterm infants and 12% (8 ⁄ 66)
in term infants (p 0.5). None of the demographic
data was associated significantly with fatal out-
come or with the duration of symptoms before
admission (Table 1). Mortality was associated
with classic severity factors, e.g. hypotension
upon admission, hypotension and seizures 12 h
after the start of treatment, and the need
for mechanical ventilation or inotropic support.
Leukopenia tended to be associated with death
Table 1. Factors predictive of death in 99 cases of Escherichia coli meningitis among infants
Variables
All infants
(n = 99)
Survived
(n = 85)
Died
(n = 14)
Univariate analysis, survival vs. death
OR CI p
Demographic data
Birth weight (g) 2892 ± 812 2909 ± 800 2791 ± 880 0.6
Gestational age <37 weeks 33 ⁄ 99 (33%) 27 (32%) 6 (43%) 0.5
Gestational age (weeks) 37.3 ± 3.3 37.2 ± 3.4 36.4 ± 3.0 0.35
Postnatal age, days (range) 10 (0–90) 11 (0–90) 5 (3–30) 0.14
Initial presentation
Duration of symptoms <24 h 64 ⁄ 91 (70%) 56 ⁄ 82 (68%) 8 ⁄ 9 (89%) 0.3
Thermal instability 61 ⁄ 82 (74%) 56 ⁄ 72 (78%) 5 ⁄ 10 (50%) 0.1
Irritability, lethargy, poor feeding 29 ⁄ 91 (32%) 28 ⁄ 82 (34%) 1 ⁄ 9 (11%) 0.3
Hypotension upon admission 13 ⁄ 99 (13%) 7 (8%) 6 (43%) 8.4 (1.9–38) 0.002
Seizures 13 ⁄ 99 (13%) 9 (10%) 3 (21%) 0.3
Apnoea 20 ⁄ 99 (20%) 16 (19) 4 (28) 0.5
Outcome 12 h after admission
Ventilation ± inotropes 34 ⁄ 99 (34%) 22 (26%) 14 (100%) <10)4
Hypotension 11 ⁄ 99 (11%) 3 (3%) 8 (57%) 36 (6–244) <10)4
Seizures 26 ⁄ 99 (26%) 16 (19%) 10 (71%) 10.7 (2.6–48) <10)4
Initial biological data
WBC <5000 ⁄mm3 19 ⁄ 70 (27%) 14 ⁄ 61 (23%) 5 ⁄ 9 (55%) 0.054
CSF glucose, mmol ⁄L (range) 0.9 (0–7) 0.9 (0–7) 0.4 (0–3.1) 0.15
CSF protein, g ⁄L (range) 2.6 (0.6–15) 2.6 (0.6–15) 2.9 (1.1–9.7) 0.46
Positive blood culture 64 ⁄ 79 (81%) 58 ⁄ 69 (84%) 6 ⁄ 10 (60%) 0.09
Other data
Abnormal initial
trans-fontanellar ultrasound
27 ⁄ 83 (33%) 20 ⁄ 72 (28%) 7 ⁄ 11 (63) 4.5 (1–21) 0.03
Treatment
Ciprofloxacin addition 43 ⁄ 98 (44%) 37 ⁄ 85 (43%) 6 ⁄ 13 (46) 0.9
E. coli phylogenetic group
A 5 5 (6%) 0 1
B1 1 0 1 (7) 0.14
B2 78 67 (79%) 11 (79) 1
D 15 13 (15%) 2 (14) 1
Common sequence O types 77 70 (82%) 7 (50) 0.21 (0.21–0.81) 0.013
STc29O1 7 7 (8%) 0 0.5
STc29O18 28 26 (31%) 2 (14%) 0.3
STc29O45 26 23 (27%) 3 (21%) 0.75
STc301O7 4 4 (5%) 0 1
STc304O16 1 1 (1%) 0 1
STc697O83 5 4 (5%) 1 (7%) 1
STc700O1 6 5 (6%) 1 (7%) 1
Uncommon sequence O types 22 15 (18%) 7 (50%) 4.67 (1.2–17.9) 0.013
Virulence determinants
Antigen K1 92 78 (92%) 14 (100%) 0.6
papC 55 50 (59%) 5 (36%) 0.18
papGII 49 44 (52%) 5 (36%) 0.4
papGIII 3 3 (3%) 0 1
sfaS 30 27 (32%) 3 (21%) 0.54
ibeA 39 31 (36%) 8 (57%) 0.14
iucC 90 80 (94%) 10 (71%) 0.16 (0.03–0.84) 0.02
iroN 74 64 (75%) 10 (71%) 0.7
hlyC 16 14 (16%) 2 (14%) 1
cnf1 11 9 (10%) 2 (14%) 0.6
fyuA 94 80 (94%) 14 (100%) 1
CSF, cerebrospinal fluid; WBC, white blood cell count.
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(p 0.054). Abnormal initial trans-fontanellar ultra-
sound findings were associated with death
(p 0.03), but no particular abnormality was asso-
ciated significantly with death. Addition of cip-
rofloxacin treatment on the first day of treatment
did not influence vital outcome significantly. The
prevalence of the common sequence O types was
significantly higher among survivors than among
non-survivors (82% vs. 50%, p 0.013). None
of the virulence determinants was distributed
differently between survivors and non-survivors,
except that the aerobactin gene (iucC) was less
frequent among lethal isolates (94% vs. 71%,
p 0.02).
Experimental virulence
Lethal isolates harbouring uncommon sequence O
types were tested in a neonatal rat model of
bacteraemia, in comparison with isolates belong-
ing to common sequence O types, e.g. C5
(STc29O18) and S88 (STc29O45) (Table 2). All but
one (S180) of these isolates caused significantly
lower levels of bacteraemia than the archetypal
C5 and S88 strains.
DISCUSSION
In the present study, the mortality rate of a
significant population of infants with E. coli men-
ingitis was 14%, a value lower than that reported
in previous studies by Mulder et al. [11] (26%, 132
patients, 1976–1982), De Louvois et al. [12] (23%,
99 patients, 1985–1987), and Unhanand et al. [13]
(19%, 52 patients, 1969–1989), but closer to the
rate observed in the most recent study by Holt
et al. [14] (15%, 26 patients, 1996–1997). Della-
grammaticas et al. [15], who only studied term
neonates, reported the lowest mortality rate (6%,
49 patients, 1983–1997). This apparent fall over
time in the case fatality rate may be attributed, at
least in part, to advances in neonatal intensive
care and to the use of third-generation cephalo-
sporins [16].
No pre-onset clinical features, including young
age, preterm birth and low body weight, were
found to be associated significantly with fatal
outcome. Unhanand et al. [13] studied Gram-
negative bacterial meningitis, and found no sig-
nificant difference in mortality between term
(14%) and preterm infants (22%). However,
Mulder et al. [11] specifically examined the mor-
tality rate of E. coli meningitis according to term,
and found a significant difference (36% among
preterm neonates and 19% among term neo-
nates). The absence of such a difference in the
present study may be associated with advances in
the management of very premature infants.
Indeed, the mortality rate among neonates with
a gestational age of <32 weeks was 67% (8 ⁄ 12) in
the study of Mulder et al. [11], performed before
1982, and only 10% (1 ⁄ 10) in the present series
(p 0.01, data not shown).
The main finding of the present study concerns
the relationship between strain characteristics and
lethality. Isolates belonging to uncommon
sequence O types were less frequent among term
infants than among preterm infants. Given the
impaired innate immunity of premature infants
[17,18], this suggests that uncommon sequence
O type E. coli strains may have a lower capacity to
circumvent innate defences in term infants than
that of common sequence O type strains. Indeed,
uncommon sequence O type isolates had signif-
Table 2. Fatal cases of Escherichia coli meningitis associated with uncommon sequence O type isolates
Characteristics of the patients Characteristics of the strains
Age
(days)
Term
(weeks)
Birth
weight (g)
Strain
number
Sequence
O typea
Phylogenetic
group
Virulence genotype Level of bacteraemia in
experimental model
(mean log CFU ⁄mL)papGII sfaS ibeA iucC iroN hlyC cnf1 fyuA
3 36 1900 S176 STc260O77 D + ) ) + ) ) ) + 3 ± 1b
16 29 1400 S180 STc689ONT B2 ) ) + + + ) ) + 6.4 ± 0.3
10 36.4 3220 S134 STc279ONT B2 ) ) + ) ) ) ) + <2b
4 38 2950 S98 STc280O35 B2 ) ) + ) + ) ) + 2 ± 0.6b
5 38 2780 S11 STc354O35 B2 ) ) + ) + ) ) + 2.1 ± 0.1b
22 39 4500 S51 STc379O128 B1 ) ) ) ) ) ) ) + <2b
5 34 1880 S162 STc698O14 B2 ) ) + + + ) ) + 2.2 ± 0.4b
C5c STc29O18 B2 ) + + ) + + + + 5.6 ± 1
S88c STc29O45 B2 + ) ) + + ) ) + 6.5 ± 0.5
aAll strains were K1-positive.
bp <0.001 vs. archetypal strain.
cArchetypal strain for comparison.
688 Clinical Microbiology and Infection, Volume 14 Number 7, July 2008
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 12, 685–690
icantly fewer virulence factors than their more
common counterparts. This is in keeping with
previous reports showing that ECM isolates
belonging to less virulent groups are obtained
only from high-risk patients, indicating that bac-
terial meningitis results from an altered balance
between host defences and E. coli virulence
[19,20]. However, paradoxically, these apparently
less virulent isolates were associated with a
higher mortality rate than their more virulent
counterparts (32% vs. 9%, p 0.01), whereas mor-
tality was not related to term ⁄preterm birth status
(Table 1).
In the same way, the absence of aerobactin was
associated with a fatal outcome. Previous studies
have also linked an absence of certain virulence
factors to E. coli-related mortality. Mulder et al.
[11] found a significantly higher mortality rate
in neonates infected with non-K1 strains, and
Hekker et al. [21] found that isolates harbouring
fewer virulence determinants tend to be associ-
ated with fatal E. coli bacteraemia in adults.
However, these studies did not assess the viru-
lence of the lethal strains experimentally. In the
present study, most of the lethal isolates harbour-
ing uncommon sequence O types were shown to
cause a significantly lower level of bacteraemia, in
a neonatal rat model, which was under the
threshold (103 CFU ⁄mL) needed to breach the
blood–brain barrier [22], and were thus less
virulent than isolates belonging to the common
sequence O types STc29O18 and STc29O45. All of
these findings suggest that there may be predis-
posing factors involved when infants aged
<3 months die from meningitis caused by uncom-
mon E. coli sequence O types. Owing to the low
incidence of E. coli meningitis, we opted for a
retrospective and multicentre study design. This
may represent a limitation, but the present study
is, nonetheless, the largest comprehensive study
of young infants with ECM, and is also the first
attempt to link vital outcome with molecular
characteristics of the isolates.
In summary, ECM in young infants is still
frequently fatal (14%). The present results indi-
cate that mortality in this setting is related more
closely to poorly virulent strains harbouring
uncommon sequence O types than to known
host-compromising factors. Genetic risk-factors
for severe infections, e.g. polymorphisms in
inflammation signalling pathways [23–25], are
beginning to be identified. It would be interesting
to examine immunity in young infants with
‘opportunistic’ ECM.
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